Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?

by Shmuel Levit, Shmuel Giveon, Yury I. Philippov, Ivan Panchev Domuschiev, Amir Zivony
Published 2016-09-01

Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery

by Vladimir A. Karpelyev, Yury I. Philippov, Artem V. Averin, Maxim D. Boyarsky, Dmitriy A. Gavrilov
Published 2018-03-01

Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin...

by Marina V. Shestakova, Natalia V. Efremova, Lubov L. Bolotskaya, Igor A. Sklyanik, Yury I. Philippov, Ivan Iю Dedov
Published 2016-12-01

Free-living use of artificial pancreas for children with type 1 diabetes: systematic review

by Klemen Dovc, Gül Yeşiltepe Mutlu, Yury I. Philippov, Dmitry N. Laptev, Evgenia M. Patrakeeva, Lubov O. Chernilova, Alsu G. Zalevskaya, Marina V. Shestakova, Tadej Battelino
Published 2018-08-01

Association of polymorphic markers of genes FTO, KCNJ11, CDKAL1, SLC30A8, and CDKN2B with type 2 diabetes mellitus in the Russian population

by Aleksey G. Nikitin, Viktor Y. Potapov, Olga I. Brovkina, Ekaterina O. Koksharova, Dmitry S. Khodyrev, Yury I. Philippov, Marina S. Michurova, Minara S. Shamkhalova, Olga K. Vikulova, Svetlana A. Smetanina, Lyudmila A. Suplotova, Irina V. Kononenko, Viktor Y. Kalashnikov, Olga M. Smirnova, Alexander Y. Mayorov, Valery V. Nosikov, Alexander V. Averyanov, Marina V. Shestakova
Published 2017-07-01